Table 4. Detection of HBV 1762^T/1764^A mutations: pre- and post-liver cancer diagnosis.

	No. of individuals prediagnosis	No. of individuals postdiagnosis
Percent of individuals with mutation
0%	7 (46.7%)*	3 (27.3%)†
>0-50%	2 (13.3%)*	2 (18.2%)†
51% to < 100%	2 (13.3%)*	2 (18.2%)†
100%	4 (26.7%)*	4 (36.4%)†
Percent of mutant samples (95% confidence interval)	42.6% (23.9, 63.6)	52.1% (29.8, 73.5)
Persistence of mutation (P value)	0.414 (P = 0.022)	0.181 (P = 0.213)

^*n = 15.

^†n = 11.